Health
FDA Panel Reviews Moderna Flu Vaccine
The FDA’s vaccine advisory panel is set to review Moderna's mRNA flu shot. The meeting comes as the company seeks approval for its candidate, with advisors reportedly open to the possibility.
Coverage timeline — 2 articles
MarketWatch
The U.S. government’s official 2% annual inflation target has suddenly been thrown into doubt by Kevin Warsh and J.D. Vance.
2026-06-17 23:00 UTC
The Hill
Presented by Philip Morris International {beacon} View Online Health Care Health Care PRESENTED BY The Big Story FDA panel set to review Moderna mRNA flu shot FDA’s vaccine advisors seem open to Moderna’s candidate for a mRNA flu vaccine ahead of a key meeting on Thursday. The company is seeki
2026-06-17 23:00 UTC